hepatic OAT Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of hepatic OAT monoclonal antibodies for advanced research in liver function and transport mechanisms. hepatic OAT Antibodies are available for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Hepatic OAT (Organic Anion Transporter) proteins facilitate the uptake and excretion of various endogenous and exogenous compounds, including drugs and metabolites. The role of hepatic OAT proteins is essential for maintaining homeostasis and detoxifying harmful substances in the liver, making them significant in pharmacokinetics and drug development. Research focused on hepatic OAT expression and regulation can provide insights into liver diseases and therapeutic interventions. Scientists studying liver transport mechanisms can utilize hepatic OAT monoclonal antibodies to advance their understanding of cellular processes. Investigating hepatic OAT proteins contributes to the development of targeted therapeutic strategies for liver disorders. Research with hepatic OAT monoclonal antibodies from Santa Cruz Biotechnology enables scientists worldwide to make meaningful discoveries in liver disease research and drug development.